These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 27829320)

  • 1. A study of the allosteric inhibition of HCV RNA-dependent RNA polymerase and implementing virtual screening for the selection of promising dual-site inhibitors with low resistance potential.
    Ismail NSM; Elzahabi HSA; Sabry P; Baselious FN; AbdelMalak AS; Hanna F
    J Recept Signal Transduct Res; 2017 Aug; 37(4):341-354. PubMed ID: 27829320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple e-pharmacophore modeling, 3D-QSAR, and high-throughput virtual screening of hepatitis C virus NS5B polymerase inhibitors.
    Therese PJ; Manvar D; Kondepudi S; Battu MB; Sriram D; Basu A; Yogeeswari P; Kaushik-Basu N
    J Chem Inf Model; 2014 Feb; 54(2):539-52. PubMed ID: 24460140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining 3-D quantitative structure-activity relationship with ligand based and structure based alignment procedures for in silico screening of new hepatitis C virus NS5B polymerase inhibitors.
    Musmuca I; Caroli A; Mai A; Kaushik-Basu N; Arora P; Ragno R
    J Chem Inf Model; 2010 Apr; 50(4):662-76. PubMed ID: 20225870
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple virtual screening approaches for finding new hepatitis C virus RNA-dependent RNA polymerase inhibitors: structure-based screens and molecular dynamics for the pursue of new poly pharmacological inhibitors.
    Elhefnawi M; ElGamacy M; Fares M
    BMC Bioinformatics; 2012; 13 Suppl 17(Suppl 17):S5. PubMed ID: 23282180
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Searching for anthranilic acid-based thumb pocket 2 HCV NS5B polymerase inhibitors through a combination of molecular docking, 3D-QSAR and virtual screening.
    Vrontaki E; Melagraki G; Mavromoustakos T; Afantitis A
    J Enzyme Inhib Med Chem; 2016; 31(1):38-52. PubMed ID: 26060939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insight into the structural requirements of benzothiadiazine scaffold-based derivatives as hepatitis C virus NS5B polymerase inhibitors using 3D-QSAR, molecular docking and molecular dynamics.
    Zhang HX; Li Y; Wang X; Xiao ZT; Wang YH
    Curr Med Chem; 2011; 18(26):4019-28. PubMed ID: 21824089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitors.
    Patil VM; Gupta SP; Samanta S; Masand N
    Med Chem; 2012 Nov; 8(6):1099-107. PubMed ID: 22779799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of Novel Hepatitis C Virus NS5B Polymerase Inhibitors by Combining Random Forest, Multiple e-Pharmacophore Modeling and Docking.
    Wei Y; Li J; Qing J; Huang M; Wu M; Gao F; Li D; Hong Z; Kong L; Huang W; Lin J
    PLoS One; 2016; 11(2):e0148181. PubMed ID: 26845440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-nucleoside inhibitors of NS5B polymerase binding to allosteric sites: 3D- QSAR and molecular docking studies.
    Cao H; Cao R; Zhang H; Zheng X; Gao D
    Curr Med Chem; 2008; 15(15):1462-77. PubMed ID: 18537623
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of hepatitis C virus replication by Monascus pigment derivatives that interfere with viral RNA polymerase activity and the mevalonate biosynthesis pathway.
    Sun JM; Kim SJ; Kim GW; Rhee JK; Kim ND; Jung H; Jeun J; Lee SH; Han SH; Shin CS; Oh JW
    J Antimicrob Chemother; 2012 Jan; 67(1):49-58. PubMed ID: 22076990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of hit molecules targeting allosteric site of hepatitis C virus NS5B polymerase.
    Polamreddy P; Vishwakarma V; Arumugam P; Bheemanati R; Esram P; Mahto MK; Kacker P
    J Biomol Struct Dyn; 2020 Mar; 38(5):1448-1466. PubMed ID: 31007134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. QSAR study of C allosteric binding site of HCV NS5B polymerase inhibitors by support vector machine.
    Pourbasheer E; Riahi S; Ganjali MR; Norouzi P
    Mol Divers; 2011 Aug; 15(3):645-53. PubMed ID: 20931278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of potential inhibitors for HCV NS5b of genotype 4a by combining dynamic simulation, protein-ligand interaction fingerprint, 3D pharmacophore, docking and 3D QSAR.
    El-Hassab MAE; El-Bastawissy EE; El-Moselhy TF
    J Biomol Struct Dyn; 2020 Sep; 38(15):4521-4535. PubMed ID: 31647392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accounting for target flexibility and water molecules by docking to ensembles of target structures: the HCV NS5B palm site I inhibitors case study.
    Barreca ML; Iraci N; Manfroni G; Gaetani R; Guercini C; Sabatini S; Tabarrini O; Cecchetti V
    J Chem Inf Model; 2014 Feb; 54(2):481-97. PubMed ID: 23952658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting HIV/HCV Coinfection Using a Machine Learning-Based Multiple Quantitative Structure-Activity Relationships (Multiple QSAR) Method.
    Wei Y; Li W; Du T; Hong Z; Lin J
    Int J Mol Sci; 2019 Jul; 20(14):. PubMed ID: 31336592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of novel VP35 inhibitors: Virtual screening driven new scaffolds.
    Ren JX; Zhang RT; Zhang H; Cao XS; Liu LK; Xie Y
    Biomed Pharmacother; 2016 Dec; 84():199-207. PubMed ID: 27657828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potential Zika virus RNA polymerase inhibitors by docking-based virtual screening.
    Singh A; Jana NK
    Comput Biol Chem; 2017 Dec; 71():144-151. PubMed ID: 29096380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploiting ChEMBL database to identify indole analogs as HCV replication inhibitors.
    Vrontaki E; Melagraki G; Mavromoustakos T; Afantitis A
    Methods; 2015 Jan; 71():4-13. PubMed ID: 24680700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A highly selective structure-based virtual screening model of Palm I allosteric inhibitors of HCV Ns5b polymerase enzyme and its application in the discovery and optimization of new analogues.
    Mahmoud AH; Abou El Ella DA; Ismail MA; Abouzid KA
    Eur J Med Chem; 2012 Nov; 57():468-82. PubMed ID: 22824204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of novel tricyclic indole derived inhibitors of HCV NS5B RNA dependent RNA polymerase.
    Venkatraman S; Velazquez F; Gavalas S; Wu W; Chen KX; Nair AG; Bennett F; Huang Y; Pinto P; Jiang Y; Selyutin O; Vibulbhan B; Zeng Q; Lesburg C; Duca J; Huang HC; Agrawal S; Jiang CK; Ferrari E; Li C; Kozlowski J; Rosenblum S; Shih NY; Njoroge FG
    Bioorg Med Chem; 2013 Apr; 21(7):2007-17. PubMed ID: 23434368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.